Physician profile
Benjamin James Widmer
NPI 1871760439
$160,184.86
in general payments reported to CMS, 2019-2025
16 companies · $16K in 2025
The $16K reported for 2025 was more than what 90% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23K · 2020: $4,234 · 2021: $40K · 2022: $19K · 2023: $22K · 2024: $36K · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $66K · Travel and Lodging: $6,922 · Food and Beverage: $1,187 · Education: $154.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $65,880.00 |
| Travel and Lodging | $6,921.63 |
| Food and Beverage | $1,186.56 |
| Education | $154.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Encore Medical, LP | $132,261.22 | 2019-2025 | Djo Surgical |
| Medical Device Business Services, INC. | $15,605.52 | 2019-2023 | Vapr, Fms, N/A |
| Depuy Synthes Products, INC. | $10,746.12 | 2021-2022 | |
| Depuy Synthes Sales INC. | $332.25 | 2022-2025 | Healix Knotless Peek, Dynacord, Bristow Latarjet |
| Stryker Corporation | $280.70 | 2021-2024 | Aequalis Perform Reversed, Blueprint Patient Specific Instrumentation, Aequalis Perform |
| Biorez, INC. | $275.36 | 2022 | |
| Zimmer Biomet Holdings, INC. | $154.04 | 2024 | Persona |
| Wright Medical Technology, INC. | $121.09 | 2020 | |
| Catalyst Orthoscience | $116.66 | 2019 | |
| Linvatec Corporation | $115.30 | 2023 | Biobrace 23mm |
| Lima USA, INC. | $48.41 | 2019 | |
| Pacira Therapeutics, INC. | $33.98 | 2019 | |
| Orthofix Medical, INC. | $29.34 | 2023 | Physio-Stim |
| Ethicon US, LLC | $28.90 | 2021 | |
| Smith+Nephew, INC. | $18.44 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $17.53 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Widmer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.